View in EDS HTML Full Text PDF Full Text

Rocatinlimab: A Novel T-Cell Rebalancing Therapy Targeting the OX40 Receptor in Atopic Dermatitis.

Saved in:
Bibliographic Details
Title: Rocatinlimab: A Novel T-Cell Rebalancing Therapy Targeting the OX40 Receptor in Atopic Dermatitis.
Authors: Guttman-Yassky, Emma1 (AUTHOR) emma.guttman@mountsinai.org, Simpson, Eric2 (AUTHOR) simpsone@ohsu.edu, Esfandiari, Ehsanollah3 (AUTHOR) ehsanollah.esfandiari@kyowakirin.com, Mano, Hirotaka4 (AUTHOR) hirotaka.mano.1h@kyowakirin.com, Bauer, Jillian5 (AUTHOR) jillianc@amgen.com, Charuworn, Prista5 (AUTHOR), Kabashima, Kenji6 (AUTHOR) kaba@kuhp.kyoto-u.ac.jp
Source: Dermatology & Therapy. Nov2025, Vol. 15 Issue 11, p3153-3171. 19p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:21938210
DOI:10.1007/s13555-025-01492-1